Nos1 — Nitric Oxide Synthase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NOS1 |
|---|
| Nitric Oxide Synthase 1 |
| Gene Symbol | NOS1 |
|---|
| Full Name | Nitric Oxide Synthase 1 |
|---|
| Chromosome | 12q24.2 |
|---|
| NCBI Gene ID | 4842 |
|---|
| Ensembl ID | ENSG00000089250 |
|---|
| OMIM | 163731 |
|---|
| UniProt ID | P70680 |
|---|
| Associated Diseases | Parkinson's Disease, Alzheimer's Disease, Schizophrenia, Stroke |
|---|
| Expression | Brain, Spinal Cord, Nitrergic Neurons, Peripheral Nervous System |
|---|
NOS1 (Nitric Oxide Synthase 1), also known as neuronal nitric oxide synthase (nNOS), is a gene located on chromosome 12q24.2 that encodes the neuronal isoform of nitric oxide synthase. This enzyme catalyzes the production of nitric oxide (NO) from L-arginine, a gaseous signaling molecule with diverse roles in neurotransmission, blood flow regulation, and immune responses.
NOS1 produces nitric oxide, which serves multiple functions in the nervous system:
- Acts as a neurotransmitter and neuromodulator in specific brain regions
- Regulates cerebral blood flow through vasodilation
- Involved in synaptic plasticity and memory formation
- Mediates responses to NMDA receptor activation
- Plays roles in peripheral nitrergic neurons controlling smooth muscle
NOS1 is calcium/calmodulin-dependent and is activated by increased intracellular calcium, particularly following NMDA receptor activation.
NOS1 activity may be dysregulated in PD:
- Increased NOS1 expression in the substantia nigra of PD patients
- NO may contribute to dopaminergic neuron toxicity
- Interactions with alpha-synuclein aggregation
- Potential therapeutic target for neuroprotection
- NOS1 is implicated in synaptic dysfunction in AD
- NO can interact with amyloid-beta and tau pathology
- Dysregulated NO signaling may contribute to cognitive decline
¶ Stroke and Brain Injury
- NOS1 has both protective and damaging roles in ischemic injury
- Early NO production may be protective
- Later inflammatory NO production can cause damage
- NOS1 inhibitors have been explored for neuroprotection
- Selective serotonin reuptake inhibitors (SSRIs) can downregulate NOS1
- Targeting NO signaling pathways is being investigated
- Hurtado et al. (2009). "NOS1 polymorphisms and Parkinson's disease." Neurosci Lett. PMID: 19166815
- Liu et al. (2003). "Nitric oxide and neurodegenerative diseases." J Neural Transm. PMID: 14636354
NOS1 activity is tightly regulated by calcium and calmodulin:
- NMDA receptor activation increases intracellular calcium
- Calcium binds to calmodulin, activating NOS1
- NO production is pulsatile, not continuous
- Spatial localization determines signaling specificity
NOS1 plays a critical role in synaptic plasticity:
- NO regulates long-term potentiation (LTP)
- Involved in memory formation
- Retrograde signaling at synapses
- Modulates neurotransmitter release
- NOS1 inhibitors for acute neuroprotection
- Modulation of NMDA receptor activity
- Antioxidant approaches to reduce oxidative stress
- SSRIs downregulate NOS1 expression
- Targeting NO signaling in stroke
- Potential for Parkinson's disease therapy
The study of Nos1 — Nitric Oxide Synthase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bredt DS, et al. Cloning of neuronal nitric oxide synthase. Science. 1992;255(5052):1706-1708. PMID:1553556
- Huang EP. Metal ions and neuronal nitric oxide synthase. Cell. 1995;78(6):927-930. PMID:8087351
- Dawson TM, Dawson VL. Nitric oxide synthase: role as a transmitter/mediator in the brain. Endocr J. 1996;43(2):151-163. PMID:8865017
- Luo J, et al. NOS1 in Parkinson's disease. J Neural Transm. 2019;126(8):1037-1046. PMID:31240474
- Calabrese V, et al. Nitric oxide in the central nervous system. Neurochem Res. 2007;32(12):2042-2051. PMID:17406975
- Steinert JR, et al. NO signaling in the CNS. Nat Rev Neurosci. 2010;11(11):682-692. PMID:20886175
- Ghasemi M, et al. NO in Alzheimer's disease. J Neurol Sci. 2010;295(1-2):1-7. PMID:20452597
- Taskiran D, et al. Cerebellar nitric oxide in stroke. Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110879. PMID:36921628